NCT07472803 Longitudinal Body Composition Assessment in Breast Cancer Patients
| NCT ID | NCT07472803 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
| Condition | Breast Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-05-19 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-05-19 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational cohort study aims to track longitudinal changes in body composition, including skeletal muscle mass and fat distribution, in patients diagnosed with breast cancer. Following primary surgery and adjuvant therapy, participants will be monitored over a 2-year period. The primary objective is to evaluate the natural progression of skeletal muscle mass index (SMI) and metabolic changes in this population. By conducting serial measurements, this study seeks to characterize the longitudinal trends in muscle loss and body composition shifts post-treatment, providing data to better understand the physiological impact of the cancer recovery process.
Eligibility Criteria
Inclusion Criteria: * \>18 years of age * Diagnosed with stage I-III non-metastatic breast cancer within 12 months of diagnosis * Scheduled for surgery, chemotherapy, with or without radiotherapy or targeted therapy. Exclusion Criteria: * Women diagnosed with metastatic (stage IV) breast cancer * Women planning to move away from the area or be away for more than 6 months during the study period * Women planning to become pregnant during the study period * Implantable devices (e.g., pacemaker, nerve stimulator) or surgical implants (e.g., total hip or knee replacements)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07472803 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07472803 currently recruiting?
Yes, NCT07472803 is actively recruiting participants. Contact the research team at haydenbell28@gmail.com for enrollment information.
Where is the NCT07472803 trial being conducted?
This trial is being conducted at New Taipei City, Taiwan.
Who is sponsoring the NCT07472803 clinical trial?
NCT07472803 is sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. The trial plans to enroll 100 participants.